Drug recall · December 23, 2015
Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg recall
Why: Labeling: Incorrect or Missing Lot AND/OR Exp Date.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Irbesartan and Hydrochlorothiazide tablets USP 150 mg/ 12.5 mg, 90-count bottles, Rx only, Manufactured in Israel by: TEVA PHARMACEUTICAL INDUSTRIES LTD Jerusalem, 971010 Israel, Manufactured for: TEVA PHARMACEUTICAL INDUSTRIES USA Sellersville, PA 18960. NDC 0093-8238-98
- Lots / codes
Lot #: 24I030, Exp 5/2017
- Quantity
- 3536 bottles
- Company
- Teva Pharmaceutical Industries, Jerusalem, N/A
- Distribution
- Nationwide
- Initiated
- October 20, 2015 · Voluntary: Firm initiated
- Classified
- December 17, 2015
- Reported
- December 23, 2015
- Ended
- November 1, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrochlorothiazide / irbesartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.